SNDX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SNDXSyndax Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SNDXSyndax Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SNDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±7.7%▲+4.40%×0.57

Q1 FY26±11.8%▼−10.83%×0.92

Feb 27 '26±10.1%▲+5.03%×0.50

Jan 13 '26±21.6%▼−1.21%×0.06

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedSNDX realized, solidLLY realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

SNDXSyndax Pharmaceuticals Inc

12.95▼−5.10%

Mkt cap$1.2BRevenue$73MQ2 FY26Revenue$172MFY25

LLYELI Lilly & Co

1,420.79▲+0.23%

Regular sessionNov 2 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 2 '26

SNDXSyndax Pharmaceuticals Inc

LLYELI Lilly & Co

12.95▼−5.10%

Price

1,420.79▲+0.23%

$1.2B

Mkt cap

$1.3T

Q2 FY26$73M

Revenue

$24.4BQ3 FY26

FY25$172M

Revenue

$65.2BFY25

SNDX12.95▼−5.10%vsLLY1,420.79▲+0.23%Regular sessionNov 2 '26